These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9127150)

  • 41. microRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.
    Marcais A; Blevins R; Graumann J; Feytout A; Dharmalingam G; Carroll T; Amado IF; Bruno L; Lee K; Walzer T; Mann M; Freitas AA; Boothby M; Fisher AG; Merkenschlager M
    J Exp Med; 2014 Oct; 211(11):2281-95. PubMed ID: 25311506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Th2 cell clonal anergy as a consequence of partial activation.
    Sloan-Lancaster J; Evavold BD; Allen PM
    J Exp Med; 1994 Oct; 180(4):1195-205. PubMed ID: 7931057
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro.
    Steenbakkers PG; Boots AM; Rijnders AW
    Immunology; 1999 Apr; 96(4):586-94. PubMed ID: 10233745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Defective activation of protein kinase C and Ras-ERK pathways limits IL-2 production and proliferation by CD4+CD25+ regulatory T cells.
    Hickman SP; Yang J; Thomas RM; Wells AD; Turka LA
    J Immunol; 2006 Aug; 177(4):2186-94. PubMed ID: 16887978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for self and nonself peptide partial agonists that prolong clonal survival of mature T cells in vitro.
    Matsushita S; Kohsaka H; Nishimura Y
    J Immunol; 1997 Jun; 158(12):5685-91. PubMed ID: 9190917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Destabilization of peptide:MHC interaction induces IL-2 resistant anergy in diabetogenic T cells.
    Edwards LJ; Evavold BD
    J Autoimmun; 2013 Aug; 44():82-90. PubMed ID: 23895744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium-mediated induction of anergy in the Jurkat T-cell line.
    Gallichio MH; Conti DJ; Lempert N; Gruber SA; Geiselhart L; Freed BM
    Transplant Proc; 1994 Dec; 26(6):3458-9. PubMed ID: 7998221
    [No Abstract]   [Full Text] [Related]  

  • 48. Differential T cell signaling induced by antagonist peptide-MHC complexes and the associated phenotypic responses.
    La Face DM; Couture C; Anderson K; Shih G; Alexander J; Sette A; Mustelin T; Altman A; Grey HM
    J Immunol; 1997 Mar; 158(5):2057-64. PubMed ID: 9036949
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of in vitro T cell clonal anergy by IL-2 stimulation.
    Beverly B; Kang SM; Lenardo MJ; Schwartz RH
    Int Immunol; 1992 Jun; 4(6):661-71. PubMed ID: 1616898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. T cell clonal anergy.
    Gilbert KM
    Chem Immunol; 1994; 58():92-116. PubMed ID: 8011160
    [No Abstract]   [Full Text] [Related]  

  • 51. Clonal expansion of freshly isolated CD4T cells by randomized peptides and identification of peptide ligands using combinatorial peptide libraries.
    Matsushita S; Tanaka Y; Matsuoka T; Nakashima T
    Eur J Immunol; 2001 Aug; 31(8):2395-402. PubMed ID: 11500823
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TCR antagonism and T cell tolerance can be independently induced in a DR-restricted, hemagglutinin-specific T cell clone.
    Alexander J; Ruppert J; Snoke K; Sette A
    Int Immunol; 1994 Mar; 6(3):363-7. PubMed ID: 8186187
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy.
    Mocholi E; Dowling SD; Botbol Y; Gruber RC; Ray AK; Vastert S; Shafit-Zagardo B; Coffer PJ; Macian F
    Cell Rep; 2018 Jul; 24(5):1136-1150. PubMed ID: 30067971
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular interactions at the T cell-antigen-presenting cell interface.
    Gascoigne NR; Zal T
    Curr Opin Immunol; 2004 Feb; 16(1):114-9. PubMed ID: 14734119
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune cell signaling defects in lupus: activation, anergy and death.
    Tsokos GC; Liossis SN
    Immunol Today; 1999 Mar; 20(3):119-24. PubMed ID: 10203702
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of T cell anergy: integration of environmental cues and infectious tolerance.
    Chappert P; Schwartz RH
    Curr Opin Immunol; 2010 Oct; 22(5):552-9. PubMed ID: 20869863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A unique unresponsive CD4+ T cell phenotype post TCR antagonism.
    Edwards LJ; Evavold BD
    Cell Immunol; 2010; 261(1):64-8. PubMed ID: 20031121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reduced transcription factor binding at the IL-2 promoter region in anergized human CD4+ T lymphocytes.
    Heisel O; Keown P
    Transplant Proc; 1999; 31(1-2):780. PubMed ID: 10083331
    [No Abstract]   [Full Text] [Related]  

  • 59. Antigen-dependent integration of opposing proximal TCR-signaling cascades determines the functional fate of T lymphocytes.
    Wolchinsky R; Hod-Marco M; Oved K; Shen-Orr SS; Bendall SC; Nolan GP; Reiter Y
    J Immunol; 2014 Mar; 192(5):2109-19. PubMed ID: 24489091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of T-cell anergy in the maintenance of donor-specific hyporesponsiveness in renal transplant recipients.
    Ng WF; Baker RJ; Hernandez-Fuentes M; Chaudhry A; Lechler RI
    Transplant Proc; 2001; 33(1-2):154-5. PubMed ID: 11266755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.